Table 2:

Demographic data of 29 patients in Cohort 2 and 14 patients in Cohort 3

Clinical characteristics*	Cohort 2 (n=29)	Cohort 3 (n= 14)
Age, years	60 (31, 76)	61.5 (43, 86)
Mean, SD	57.9 (11.2)	62.0 (13.5)
Myositis duration, years	5 (1, 22)	11.5 (5, 43)
Mean, SD	6.1 (5.3)	15.4 (10.9)
Creatine kinase (U/L)	102 (43, 850)	97 (47, 1470)
Sex, female	19 (66%)	10 (71%)
Diagnosis
PM	6 (21%)	11 (79%)
DM	15 (52%)	3 (21%)
Anti-synthetase syndrome	8 (28%)	0 (0%)
MAP score	2 (1, 5)	2 (1, 5)
HAQ score	0.8 (0, 2)	0.6 (0, 2)